Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR
Marketer
Swast Aushadhi Seva Generic Medicine Store
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR
Combiplus SR tablets (Glimepiride 1mg/Metformin 500mg/Pioglitazone 15mg) are a triple-combination medication managing blood glucose in adults with type 2 diabetes. This therapy complements diet and exercise to enhance glycemic control by improving insulin effectiveness and reducing blood sugar. Always adhere to your physician's prescribed dosage and duration. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly unless the next dose is imminent; in that case, skip the missed dose and resume the regular schedule. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetics, alcohol, or missed meals raises the hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, increased bone fracture risk, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must seek medical counsel before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption as it may intensify adverse effects.
Primary Ingredients of Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR:
Consume this medication according to your physician's prescribed dosage and regimen. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Extended-Release Tablet should be administered with meals.
Common Side effects of Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Extended-Release tablets with food.
How Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR works:
Combinazione SR di Glimepiride/Metformina/Pioglitazone (1mg/500mg/15mg) from Genericart is a triple-action antidiabetic formulation. This tablet unites Glimepiride, Metformin, and Pioglitazone, each operating via distinct pathways to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this by further improving insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The combination medication Glimepiride+Metformin+Pioglitazone (Genericart) 1mg/500mg/15mg SR tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against these risks before prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The combination drug Glimepiride+Metformin+Pioglitazone (Genericart, 1mg/500mg/15mg SR tablets) is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
The combination medication Glimepiride/Metformin/Pioglitazone (1mg/500mg/15mg SR) requires careful administration in individuals with impaired kidney function. Dosage modification may be necessary. Physician consultation is advised. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
The combination medication Glimepiride/Metformin/Pioglitazone (1mg/500mg/15mg SR) requires careful administration in individuals with hepatic impairment. Dosage modification may be necessary. Consult a physician for guidance. This medication is contraindicated for patients experiencing severe liver disease.
What if you forget to take Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR :
Should you forget a dose of Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg SR Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Genericart Glimepiride+Metformin+Pioglitazone 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently